Upcoming Rare Disease Workshop Focuses on the Importance of Data Sharing in Drug Development C-Path, NORD and FDA to host annual workshop September 13-14 to highlight the impact of their innovative data and analytics platfo
Oak Hill Bio Joins C-Path’s International Neonatal Consortium TUCSON, Ariz., Aug. 24, 2022 — Critical Path Institute (C-Path) today announced that Oak Hill Bio (Oak Hill), a clinical-stage n
C-Path’s Dr. Amanda Klein Promoted to Transplant Therapeutic Consortium Executive Director TUCSON, Ariz., July 14, 2022 — Critical Path Institute (C-Path) has named Amanda Klein, Pharm.D., as Executive Director for its
Diamyd Medical Joins International Consortium in Type 1 Diabetes TUCSON, Ariz., June 30, 2022 — Diamyd Medical will be a full voting member of the Type 1 Diabetes Consortium (T1DC) led by the U
C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, a
C-Path Receives DIA 2022 Americas Inspire Award for Outstanding Contribution to Health TUCSON, Ariz., June 22, 2022 — Critical Path Institute (C-Path) is pleased to announce it has received the DIA 2022 Ameri
C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 — Criti
June 7, 2022 C-Path and MitoAction Announce Data Sharing Agreement to Support Treatment Development in Mitochondrial Disease TUCSON, Ariz., June 7, 2022 — Critical Path Institute (C-Path) and MitoAction today announced a joint collaboration to incorpora
xCures joins C-Path’s Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repur
Biochemist, Biotechnology Expert to Lead C-Path’s Type 1 Diabetes Consortium TUCSON, Ariz., June 2, 2022 — Critical Path Institute (C-Path) has named Elnaz Atabakhsh, Ph.D., as Executive Director of its Ty